Business of Medicine
On implementation of opt-out testing, the proportion of tests performed increased from 57.9% to 69% in a study.
Reports From the Field
An influential group urges both a reduction in costs of certain obesity medicines and expanded insurance coverage of them. The recommendations are...
Provention Bio has priced its newly approved diabetes drug teplizumab far higher than some Wall Street analysts expectations.
More children in a mostly low-income cohort completed the visits and got COVID vaccines when they got an automated reminder through a patient...